| Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease A Oussalah, V Laurent, O Bruot, A Bressenot, MA Bigard, D Régent, ... Gut 59 (8), 1056-1065, 2010 | 293 | 2010 |
| Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease L Peyrin-Biroulet, A Oussalah, N Williet, C Pillot, L Bresler, MA Bigard Gut 60 (7), 930-936, 2011 | 266 | 2011 |
| Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis X Roblin, S Pillet, A Oussalah, P Berthelot, E Del Tedesco, JM Phelip, ... Official journal of the American College of Gastroenterology| ACG 106 (11 …, 2011 | 223 | 2011 |
| A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization A Oussalah, L Evesque, D Laharie, X Roblin, G Boschetti, S Nancey, ... Official journal of the American College of Gastroenterology| ACG 105 (12 …, 2010 | 221 | 2010 |
| Health outcomes associated with vegetarian diets: An umbrella review of systematic reviews and meta-analyses A Oussalah, J Levy, C Berthezène, DH Alpers, JL Guéant Clinical Nutrition 39 (11), 3283-3307, 2020 | 136 | 2020 |
| Meta‐analysis: hyperhomocysteinaemia in inflammatory bowel diseases A Oussalah, JL Guéant, L Peyrin‐Biroulet Alimentary pharmacology & therapeutics 34 (10), 1173-1184, 2011 | 135 | 2011 |
| Plasma mSEPT9: a novel circulating cell-free DNA-based epigenetic biomarker to diagnose hepatocellular carcinoma A Oussalah, S Rischer, M Bensenane, G Conroy, P Filhine-Tresarrieu, ... EBioMedicine 30, 138-147, 2018 | 133 | 2018 |
| Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy A Oussalah, JB Chevaux, R Fay, WJ Sandborn, MA Bigard, ... Official journal of the American College of Gastroenterology| ACG 105 (5 …, 2010 | 121 | 2010 |
| Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience A Oussalah, C Laclotte, JB CHEVAUX, M Bensenane, A Babouri, ... Alimentary pharmacology & therapeutics 28 (8), 966-972, 2008 | 120 | 2008 |
| Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis A Oussalah, M Julien, J Levy, O Hajjar, C Franczak, C Stephan, E Laugel, ... Journal of clinical medicine 8 (4), 551, 2019 | 108 | 2019 |
| Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France JB Chevaux, A Nani, A Oussalah, V Venard, M Bensenane, A Belle, ... Inflammatory bowel diseases 16 (6), 916-924, 2010 | 108 | 2010 |
| HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping JL Guéant, A Romano, JA Cornejo-Garcia, A Oussalah, C Chery, ... Journal of Allergy and Clinical Immunology 135 (1), 253-259. e10, 2015 | 94 | 2015 |
| CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features R Elakoum, G Gauchotte, A Oussalah, MP Wissler, C Clément-Duchêne, ... Biochimie 97, 210-218, 2014 | 93 | 2014 |
| A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients JL Guéant, C Chéry, A Oussalah, J Nadaf, D Coelho, T Josse, J Flayac, ... Nature Communications 9 (1), 67, 2018 | 83 | 2018 |
| Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive … A Oussalah, J Ferrand, P Filhine-Tresarrieu, N Aissa, I Aimone-Gastin, ... Medicine 94 (44), e1774, 2015 | 81 | 2015 |
| Elastase and exacerbation of neutrophil innate immunity are involved in multi‐visceral manifestations of COVID‐19 JL Guéant, RM Guéant‐Rodriguez, J Fromonot, A Oussalah, H Louis, ... Allergy 76 (6), 1846-1858, 2021 | 78 | 2021 |
| Long‐term outcome of non‐fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab G Bouguen, I Trouilloud, L Siproudhis, A Oussalah, MA BIGARD, ... Alimentary pharmacology & therapeutics 30 (7), 749-756, 2009 | 75 | 2009 |
| Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury R Kormann, A Jacquot, A Alla, A Corbel, M Koszutski, P Voirin, ... Clinical kidney journal 13 (3), 362-370, 2020 | 72 | 2020 |
| Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics N Williet, C Pillot, A Oussalah, V Billioud, JB Chevaux, L Bresler, ... Inflammatory bowel diseases 18 (9), 1641-1646, 2012 | 71 | 2012 |
| Crohn’s disease: the hot hypothesis L Peyrin-Biroulet, A Oussalah, MA Bigard Medical hypotheses 73 (1), 94-96, 2009 | 64 | 2009 |
jean-louis gueantInserm et Université de LorraineVerified email at univ-lorraine.fr
